Data sourcesSEC Form 424m ago
House PTR23m ago
SEC 13F23m ago
Robinhood Chain23m ago
IRulya Therapeutics, Inc. (IRLA) · INSIDER
Public companyIRulya Therapeutics, Inc.
IRLACIK 0001662774
Price$39.78
1 year-88.9%
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score15
Connections with evidence6
IRLA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 15 | MJMilitello JohnChief Financial Officer | IRLAIRulya Therapeutics, Inc.Grant or award | A | — 80.0K sh | Nov 9, 2026 | Nov 12, 2026 |
| 15 | BMBonuccelli Catherine M.Director | IRLAIRulya Therapeutics, Inc.Grant or award | A | — 17.0K sh | Nov 9, 2026 | Nov 12, 2026 traded Nov 9, 2026 | +3d | SEC Form 4 | |
| 15 | VEValentine James ElwoodDirector | IRLAIRulya Therapeutics, Inc.Grant or award | A | — 17.0K sh | Nov 9, 2026 | Nov 12, 2026 traded Nov 9, 2026 | +3d | SEC Form 4 | |
| 15 | WDWise John DraytonDirector | IRLAIRulya Therapeutics, Inc.Grant or award | A | — 17.0K sh | Nov 9, 2026 | Nov 12, 2026 traded Nov 9, 2026 | +3d | SEC Form 4 | |
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 6, 2026
Planned sales and 5% stakes
Form 144, 13D and 13G